secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2025-11-19T23:59:59+00:00
Accession:  0001193125-25-288343
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Olema Pharmaceuticals announces $190M follow-on offering of 10M shares at $19.00
--------------------------------------------------------------------------------

- Offering of 10,000,000 shares of common stock at $19.00 per share for gross proceeds of ~$190M.
- Underwriters have a 30-day option to purchase up to 1,500,000 additional shares.
- Closing expected on November 20, 2025, subject to customary conditions.
- Underwriting agreement with TD Securities (USA) LLC as representative of the underwriters.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000119312525288343/0001193125-25-288343-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000119312525288343/d46182d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-288343

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer